NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S: Financial statements 2013
CVR: 33249098
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S (CVR 33249098) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 4,172,733 and a net result of DKK 3,170,924. Equity in the 2013 report amounted to DKK 6,244,372. The solvency ratio was 6.5%.
- Gross Profit
- DKK 4,172,733
- Profit/Loss
- DKK 3,170,924
- Equity
- DKK 6,244,372
- Total Assets
- DKK 96,729,917
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 4.2 mio. | 3.2 mio. | 6.2 mio. | - |
| 2012 | - | - | - | 500 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of October 1, 2013, AIDER Godkendt Revisionsaktieselskab has been appointed auditor of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S.
As of October 1, 2013, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S.
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S has published its annual report for 2012.
As of February 6, 2013, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S.
As of February 6, 2013, Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer has stepped down as auditor of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S.
About NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S was a Danish company of the type Aktieselskab based in Herlev, founded in 2010. The company has been dissolved on 25 May 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. According to the 2019 annual report, the company had an average of 0 employees. In 2019, the company reported a gross profit of DKK 248,136 and a net result of DKK 164,772 compared with DKK 954,488 the year before. Equity in the 2019 report amounted to DKK 725,098.